Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Prepaid Assets: 2021-2025

Historic Prepaid Assets for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $17.2 million.

  • Krystal Biotech's Prepaid Assets rose 92.09% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 92.09%. This contributed to the annual value of $11.7 million for FY2024, which is 73.83% up from last year.
  • As of Q3 2025, Krystal Biotech's Prepaid Assets stood at $17.2 million, which was up 1.97% from $16.9 million recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Prepaid Assets peaked at $17.2 million during Q3 2025, and registered a low of $2.2 million during Q2 2021.
  • In the last 3 years, Krystal Biotech's Prepaid Assets had a median value of $7.7 million in 2024 and averaged $9.9 million.
  • Data for Krystal Biotech's Prepaid Assets shows a peak YoY spiked of 158.29% (in 2025) over the last 5 years.
  • Krystal Biotech's Prepaid Assets (Quarterly) stood at $4.2 million in 2021, then grew by 10.48% to $4.6 million in 2022, then soared by 45.53% to $6.7 million in 2023, then skyrocketed by 73.83% to $11.7 million in 2024, then soared by 92.09% to $17.2 million in 2025.
  • Its Prepaid Assets stands at $17.2 million for Q3 2025, versus $16.9 million for Q2 2025 and $16.8 million for Q1 2025.